Heart Disease Clinical Trials in Chicago

Showing 261-280 of 440 trials

A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure

NCT02467387

A phase IIa study to assess the safety and preliminary efficacy of intravenous dose of ischemia-tolerant Allogeneic Mesenchymal Bone Marrow Cells in subjects with non-ischemic heart failure.

Non-Ischemic Heart Failure

CardioCell LLC23 participantsStarted Jun 2014

Washington D.C., District of Columbia, United States • Atlanta, Georgia, United States • Chicago, Illinois, United States +2 more locations

COMPLETEDPhase 32.2 miles

A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome

NCT00658515

This study will evaluate the potential of RO4607381 to reduce cardiovascular morbidity and mortality in stable coronary heart disease patients with recent Acute Coronary Syndrome (ACS) and evaluate the long term safety profile of the drug. Eligible patients in stable condition will be randomized to receive either RO4607381 600mg po or placebo po, daily, together with a background of standard medication for ACS (including aspirin, antihypertensives and statins). The anticipated time on study treatment is 2+ years, and the target sample size is 15,600 individuals.

Coronary Heart Disease

Hoffmann-La Roche15,871 participantsStarted Apr 2008

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +1086 more locations

A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure

A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome

Heart Disease Trials in Other Cities

HW006 LATERAL Thoracotomy

Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis

A Study of VentriGel in Post-MI Patients

A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Preserved Ejection Fraction

Healthy Hearts in the Heartland

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

Effect of Ivabradine in Stage D HF/Cardiogenic Shock Patients on Dobutamine

VITROS Immunodiagnostic Products NT-proBNP II

Evaluation of Cardiac Compass With OptiVol in the Early Detection of Decompensation Events for Heart Failure

Evaluation of the Safety and Effectiveness of the DuraHeart™ LVAS

A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)

Mitroflow DL Post Approval Study- North America

Integrated Tele-monitoring and Patient-centric Health Coaching Strategy in Patients Hospitalized With Heart Failure

Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation

Correlation of SOZO BIS Measures With CardioMEMS PA Pressure

Patient and Provider Assessment of Lipid Management Registry

Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT)

e-NOBORI Observational Registry of Nobori DES

Other Conditions in Chicago